Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
102,559,902
-
Share change
-
+15,386,602
-
Total reported value
-
$9,730,962,931
-
Put/Call ratio
-
179%
-
Price per share
-
$94.89
-
Number of holders
-
773
-
Value change
-
+$1,468,652,699
-
Number of buys
-
376
-
Number of sells
-
314
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2024
As of 31 Mar 2024,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
773 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,559,902 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Avoro Capital Advisors LLC, BNP PARIBAS FINANCIAL MARKETS, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, CITADEL ADVISORS LLC, and UBS Group AG.
This page lists
775
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.